SlideShare a Scribd company logo
By KARISHMA SURESH ASNANI
Guided by Ms. Pradnya Gondane Mam
GURUNANAK COLLEGE OF PHARMACY
ASYMMETRIC SYNTHESIS
 Enantioselective synthesis, also called asymmetric synthesis, is a form
of chemical synthesis. It is defined by IUPAC as: a chemical reaction (or
reaction sequence) in which one or more new elements of chirality are
formed in a substrate molecule and which produces the stereoisomeric
(enantiomeric or diastereoisomeric) products in unequal amounts.
 Put more simply: it is the synthesis of a compound by a method that
favors the formation of a specific enantiomer or diastereomer.
Enantiomers are stereoisomers that have opposite configurations at
every chiral center. Diastereomers are stereoisomers that differ at one
or more chiral centers.
 Enantioselective synthesis is a key process in modern chemistry and is
particularly important in the field of pharmaceuticals, as the different
enantiomers or diastereomers of a molecule often have different
biological activity.
THE CHIRAL POOL: NATURE’S
CHIRAL CENTRES ‘OFF THE
SHELF’ A laboratory synthesis of a chiral compound from achiral or racemic
starting material alone always gives a racemic mixtures of enantiomers.
 If you want to make just one enantiomer, you have to use a starting
material or reagents which is also just one enantiomer.
 These enantiomerically pure compounds are present in abundance in
nature which are collectively known as the ‘chiral pool’.
 The principle groups of compounds in the chiral pool are:
1. Amino acids and their derivatives
2. Carbohydrates and their derivatives
AMINO ACIDS AND THEIR
DERIVATIVES
 There are n number of amino acids found in proteins, out of which some
of them are given below.
 These amino acids have simple side chain that are simple alkyl groups
or functionalized chains with plenty of versatile chemistry, and can be
obtained by hydrolysis of protein.
Simple derivatives of the amino
acids AMINO ALCOHOL: It’s easy to reduce amino acids to amino alcohols
with borane (BH3), usually generated in the reaction mixture by treating
sodium borohydride with concentrated sulfuric acid.
 Ephedrine is an amino alcohol which is itself a useful member of the
chiral pool—it’s a plant extract readily available as either
diastereoisomer, also available as either enantiomer.
 HYDROXY ACID: It’s also easy to make hydroxy acids from amino
acids by diazotization. Nitrous acid generates a diazonium salt, which
undergoes substitution by water via an intermediate α-lactone. Two
configurational inversions are involved, so the product alcohol retains S
stereochemistry.
 Some hydroxy acids are themselves available from nature, and are
therefore also members of the chiral pool: both (R)- and (S)-lactic acid,
for example, can be made by bacterial fermentation; mandelic, malic,
and tartaric acids are extracted from almonds, apples, and grapes,
respectively.
CARBOHYDRATES AND THEIR
DERIVATIVES.
 There are a great many simple carbohydrates available, but one of the
most useful is mannose. Reduction to the alcohol gives the C2-
symmetric compound mannitol, which can be converted to a useful
aldehyde by selective protection as a bis-acetal with acetone and a
Lewis acid. Cleavage of the remaining diol with sodium periodate gives
two equivalents of a useful protected form of glyceraldehyde.
 There are varied ways in which members of the chiral pool can be put to
work in asymmetric synthesis, but the most straightforward application is
simply to spot that a target molecule has a close structural similarity
with, say, an amino acid.
 This is what Mori did when he made another important insect
pheromone, ipsenol. The left-hand half of the molecule has the same
structure as the side chain of leucine, and the S chiral centre can also
come from (S)-leucine.
 Mori used (S)-leucine as the starting material and converted it
to the (S)-hydroxy acid. The hydroxyl group was protected as
the THP derivative.
 Reduction of the acid, via the ester, then allowed introduction of the
tosylate leaving group, which was displaced to make an epoxide. The
epoxide was opened by a Grignard reagent to introduce the diene
portion and give the target molecule.
CHIRAL AUXILIARIES
 A chiral auxiliary is a stereogenic group or unit that is temporarily
incorporated into an organic compound in order to control
the stereochemical outcome of the synthesis. The chirality present in the
auxiliary can bias the stereoselectivity of one or more subsequent
reactions. The auxiliary can then be typically recovered for future use.
 Diastereoselective reactions work just as well whether the starting
material is racemic or enantiomerically pure—you get the same
diastereoisomeric outcome in each case, but if you start with racemic
material you get racemic product and if you start with enantiomerically
pure material you get enantiomerically pure product.
 So if you use a starting material from the chiral pool, you can build new
chiral centres in enantiomerically pure form just by using
diastereoselective reactions. The chiral pool starting materials (S)-lactic
acid and (S)-serine were converted to two natural products using a
series of diastereoselective reactions to introduce further chiral centres
into the molecules.
 The syntheses rely on the fact that the structure of the chiral pool
starting material is still there in the product. But the same idea can work
even if the starting chiral compound is no longer part of the target you
are making. In this case the chiral starting material is called a chiral
auxiliary. Chiral auxiliaries are extremely versatile because they can be
used to make a whole variety of target molecules in enantiomerically
pure form.
OXAZOLIDINONES AUXILLARIES
 Oxazolidinone auxiliaries, popularized by David Evans, have been
applied to many stereoselective transformations, including aldol
reactions, alkylation reactions, and Diels-Alder reactions. The
oxazolidinones are substituted at the 4 and 5 positions. Through steric
hindrance, the substituents direct the direction of substitution of various
groups. The auxiliary is subsequently removed e.g. through hydrolysis.
 PREPARATION: Oxazolidinones can be prepared from amino acids or
readily available amino alcohols. A large number of oxazolidinones are
commercially available, including the four below.
 ALKYLATION REACTIONS
 Deprotonation at the α-carbon of an oxazolidinone imide with a strong
base such as lithium diisopropylamide selectively furnishes the (Z)-
enolate, which can undergo stereoselective alkylation.
 Alkylation of an oxazolidinone imide with benzyl bromide.
 Activated electrophiles, such as allylic or benzylic halides, are very good
substrates.
Removal
A variety of transformations have been developed to facilitate removal of the
oxazolidinone auxiliary to generate different synthetically useful functional
groups.
ASYMMETRIC CATALYSIS
 Definition: Asymmetric catalysis is a type of catalysis in which a chiral
catalyst directs the formation of a chiral compound such that formation
of one particular stereoisomer is favoured.
1. Catalytic asymmetric reduction of ketones
2. Catalytic asymmetric hydrogenation of alkenes
3. Asymmetric epoxidation
4. Asymmetric dihydroxylation
5. Ligand-accelerated catalysis
CATALYTIC ASYMMETRIC
REDUCTION OF KETONES
 One of the simplest transformations you could imagine of a prochiral
unit into a chiral one is the reduction of a ketone. Although chiral
auxiliary strategies have been used to make this type of reaction
asymmetric, conceptually the simplest way of getting the product as a
single enantiomer would be to use a chiral reducing agent—in other
words, to attach the chiral influence not to the substrate (as we did with
chiral auxiliaries) but to the reagent. We need an asymmetric version of
NaBH4.
 One of the more widely used solutions to this challenge is the chiral
borohydride analogue invented by Itsuno in Japan and developed by
Corey, Bakshi, and Shibata. It is based on a stable boron heterocycle
made from an amino alcohol derived from proline, and is known as the
CBS catalyst after its developers.
 The active reducing agent is generated when the heterocycle forms a
complex with borane. Only catalytic amounts (usually about 10%) of the
boron heterocycle are needed because borane is suffi ciently reactive to
reduce ketones only when complexed with the nitrogen atom. The rest
of the borane just waits until a molecule of catalyst becomes free.
 INTERACTIVE ASYMMETRIC REDUCTION
OF KETONE WITH CBS CATALYST
 Until recently, the CBS reagent was one of the most commonly used
asymmetric reducing agents for ketones. But in the early years of the
21st century a new reaction has taken over that role—one in which the
job of bringing together the ketone and the reducing agent is taken by
an atom of ruthenium.
 The ruthenium is added as Ru(II) in a 16-electron complex with an
aromatic compound such as 1,3,5-trimethylbenzene (known as
mesitylene).
 A chiral ligand is needed—the diamine derivative shown here is best.
Only very small amounts (often << 1%) of the catalyst and ligand are
required, which is a good thing as both are much more expensive than
the reagents in the CBS reduction.
 The reducing agent itself can be hydrogen or, more conveniently, a more
easily handled source of hydrogen atoms such as isopropanol (which
gets oxidized to acetone) or formic acid (which gets oxidized to carbon
dioxide).
 Here’s a typical example; will explain how it works shortly.
The ruthenium-catalysed reduction of ketones starts with coordination of the
tosyl-diamine ligand ((S,S)-N-toluenesulfonyl 1,2-phenylenediamine, or
‘TsDPEN’) to the ruthenium metal. This is a 16-electron complex, and can
be reduced by formic acid to an 18-electron ruthenium hydride.
EXAMPLE
The reduction shown below is particularly important because
it generates a late intermediate in the industrial synthesis of
the anti-asthma drug montelukast (Singulair). Several
methods have been used, but in 2008 chemists at the Croatian
pharmaceutical company Pliva patented a method using the
ruthenium catalyst with a derivative of TsDPEN as a ligand to
gives the product in 83% yield and 99.8% ee on a scale of
several kilograms.
CATALYTIC ASYMMETRIC
HYDROGENATION OF ALKENES
 Reduction of a ketone can give a chiral secondary alcohol, but reduction
of an alkene by addition of hydrogen to one of its two enantiotopic faces
can give all sorts of products, creating either one or two chiral centres,
depending on the substituents on the alkene.
 You have seen numerous hydrogenations of alkenes using hydrogen
over a solid catalyst of palladium supported on charcoal
(‘heterogeneous hydrogenation’), but catalytic asymmetric
hydrogenation of alkenes uses a different type of catalyst—a soluble
complex, often of Ru or Rh with phosphine-containing ligands.
 The substrates for asymmetric alkene hydrogenation are also more
limited than those for hydrogenation with Pd/C because they must carry
a functional group close to the alkene, allowing coordination to the
transition metal catalyst.
Two important industrial asymmetric syntheses which routinely use this
chemistry are the production of the painkiller (S)-naproxen and the synthetic
intermediate and perfumery compound (R)-citronellol. It is gratifying to note
that this chemistry, using
Asymmetric epoxidation
 Asymmetric hydrogenation of an alkene can create two new chiral
centres, but introduces no new functionality as it does so. Asymmetric
oxidation of an alkene is different: it can create two new chiral centres
and two new functional groups at the same time.
 This reaction makes use of titanium, as titanium tetraisopropoxide,
Ti(Oi-Pr)4.
 Sharpless and his co-worker Tsutomu Katsuki surmised that by adding a
chiral ligand to the titanium catalyst they might be able to make the
reaction asymmetric. The ligand that works best is diethyl tartrate, and
one example of the reaction is shown below.
 Jacobsen asymmetric epoxidation of indene
 This epoxide plays a starring role in the synthesis
of the antiHIV compound indinavir.
ASYMMETRIC DIHYDROXYLATION
 The active reagent is based on osmium(VIII) and is used in just catalytic
amounts.
 This means that there has to be a stoichiometric quantity of another
oxidant to reoxidize the osmium after each catalytic cycle—K3Fe(CN)6 is
most commonly used.
 Because OsO4 is volatile and toxic, the osmium is usually added as
K2OsO2(OH)4, which forms OsO4 in the reaction mixture.
 The ‘other additives’ include K2CO3 and methanesulfonamide
(MeSO2NH2), which increases the rate of the reaction by regenerating
the catalyst at the end of each catalytic cycle.
 Now for the chiral ligand.
 Tertiary amines are good ligands for osmium and increase the rate of
dihydroxylations: one of the reasons that NMO is used in the racemic
version of the reaction is that the by-product, N-methylmorpholine,
accelerates the reaction.
 Sharpless chose some available chiral tertiary amines as ligands, and it
turned out that the best ones are based on the alkaloids
dihydroquinidine and dihydroquinine, whose structures are shown
below.
 They coordinate to the osmium through the green nitrogen atom.
 The alkaloids (usually abbreviated to DHQD and DHQ, respectively)
must be attached to an aromatic group Ar, the choice of which varies
according to the substrate.
 The most generally applicable ligands are these two phthalazines in
which each aromatic group Ar carries two alkaloid ligands, either DHQ
or DHQD.
 Dihydroquinine and dihydroquinidine are not enantiomeric, but they act
on the dihydroxylation as though they were.
EXAMPLE
trans-Stilbene dihydroxylates more selectively than any other alkene, and
this particular example is one of the most enantioselective catalytic
reactions ever invented.
LIGAND-ACCELERATED CATALYSIS
 Asymmetric dihydroxylation is such a good reaction not just because of
the careful way in which the ligands have been designed.
 It is a good reaction for a more fundamental reason: the reaction on
which it is based (osmium-catalysed dihydroxylation) works only very
poorly in the absence of the amine ligand.
 The chiral amine ligands don’t just provide a chiral environment, they
accelerate the reaction at the same time.
 In any asymmetric reaction, we want the reagents to combine with one
another only in the presence of the asymmetric infl uence provided by
the chiral ligands.
 If the reaction works anyway, even without the chiral ligands, we have
an uphill struggle because the reagents are quite capable of producing
racemic product on their own.
STEREOSELECTIVITY
 In chemistry, stereoselectivity is the property of a chemical
reaction in which a single reactant forms an unequal mixture of
stereoisomers during a non-stereospecific creation of a new
stereocenter or during a non-stereospecific transformation of a
pre-existing one. The selectivity arises from differences in steric
effects and electronic effects in the mechanistic pathways leading
to the different products. Stereoselectivity can vary in degree but it
can never be total since the activation energy difference between
the two pathways is finite. Both products are at least possible and
merely differ in amount. However, in favorable cases, the minor
stereoisomer may not be detectable by the analytic methods
used.
 An enantioselective reaction is one in which one enantiomer is formed
in preference to the other, in a reaction that creates an optically active
product from an achiral starting material, using either a chiral catalyst,
an enzyme or a chiral reagent. The degree of selectivity is measured by
the enantiomeric excess. An important variant is kinetic resolution, in
which a pre-existing chiral center undergoes reaction with a chiral
catalyst, an enzyme or a chiral reagent such that one enantiomer reacts
faster than the other and leaves behind the less reactive enantiomer, or
in which a pre-existing chiral center influences the reactivity of a reaction
center elsewhere in the same molecule.
 A diastereoselective reaction is one in which one diastereomer is
formed in preference to another (or in which a subset of all possible
diastereomers dominates the product mixture), establishing a preferred
relative stereochemistry. In this case, either two or more chiral centers
are formed at once such that one relative stereochemistry is favored, or
a pre-existing chiral center (which needs not be optically pure) biases
the stereochemical outcome during the creation of another. The degree
of relative selectivity is measured by the diastereomeric excess.

More Related Content

What's hot

SYNTHETIC REAGENTS AND APPLICATION
SYNTHETIC REAGENTS AND APPLICATIONSYNTHETIC REAGENTS AND APPLICATION
SYNTHETIC REAGENTS AND APPLICATION
Binuja S.S
 
Methods of Asymmetric Synthesis using chiral pool 2.pptx
Methods of Asymmetric Synthesis using chiral pool 2.pptxMethods of Asymmetric Synthesis using chiral pool 2.pptx
Methods of Asymmetric Synthesis using chiral pool 2.pptx
MO.SHAHANAWAZ
 
Wiliknsons reagent
Wiliknsons reagentWiliknsons reagent
Wiliknsons reagent
Shikha Popali
 
Synthetic Reagent and Its Applications (M. Pharm)
Synthetic Reagent and Its Applications (M. Pharm)Synthetic Reagent and Its Applications (M. Pharm)
Synthetic Reagent and Its Applications (M. Pharm)
MohdShafeeque4
 
Protecting Groups In Organic Synthesis
Protecting Groups In Organic SynthesisProtecting Groups In Organic Synthesis
Protecting Groups In Organic Synthesis
Apoorv Rastogi
 
Suzuki and Shapiro reaction
Suzuki and Shapiro reaction Suzuki and Shapiro reaction
Suzuki and Shapiro reaction
Shalinee Chandra
 
Nitration
NitrationNitration
Nitration
burhanmadri
 
organic reaction
organic reactionorganic reaction
organic reaction
NiketBajare
 
Pinner pyrimidine synthesis
Pinner pyrimidine  synthesisPinner pyrimidine  synthesis
Pinner pyrimidine synthesis
JACOB THON BIOR
 
Advanced Organic Chemistry - I
Advanced Organic Chemistry - IAdvanced Organic Chemistry - I
Advanced Organic Chemistry - I
Ajay Kumar
 
Enatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTS
Enatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTSEnatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTS
Enatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTS
Shikha Popali
 
MITSUNUBU REACTION.pptx
MITSUNUBU REACTION.pptxMITSUNUBU REACTION.pptx
MITSUNUBU REACTION.pptx
TapasMajumder15
 
knorr pyrazole synthesis
knorr pyrazole synthesisknorr pyrazole synthesis
knorr pyrazole synthesis
Vishakha Giradkar
 
Ullmann reaction
Ullmann reaction   Ullmann reaction
Ullmann reaction
Aanchal Gupta
 
Heterocyclic compounds
Heterocyclic compoundsHeterocyclic compounds
Heterocyclic compounds
priyaswain27
 
Asymmetric synthesis | chemistry presentation | 2021
Asymmetric synthesis | chemistry presentation | 2021 Asymmetric synthesis | chemistry presentation | 2021
Asymmetric synthesis | chemistry presentation | 2021
ProttayDutta1
 
Strategies for Heterocycle ring synthesis
Strategies for Heterocycle ring synthesis Strategies for Heterocycle ring synthesis
Strategies for Heterocycle ring synthesis
SACHINKUMARVISHWAKAR4
 
Wittig reagent
Wittig reagentWittig reagent
Wittig reagent
andhra university
 
Asymmetric Synthesis Mpharm 1St year
Asymmetric Synthesis Mpharm 1St yearAsymmetric Synthesis Mpharm 1St year
Asymmetric Synthesis Mpharm 1St year
DhanashreeSarwan
 
Side reaction in peptide synthesis
Side reaction in peptide synthesisSide reaction in peptide synthesis
Side reaction in peptide synthesis
suraj wanjari
 

What's hot (20)

SYNTHETIC REAGENTS AND APPLICATION
SYNTHETIC REAGENTS AND APPLICATIONSYNTHETIC REAGENTS AND APPLICATION
SYNTHETIC REAGENTS AND APPLICATION
 
Methods of Asymmetric Synthesis using chiral pool 2.pptx
Methods of Asymmetric Synthesis using chiral pool 2.pptxMethods of Asymmetric Synthesis using chiral pool 2.pptx
Methods of Asymmetric Synthesis using chiral pool 2.pptx
 
Wiliknsons reagent
Wiliknsons reagentWiliknsons reagent
Wiliknsons reagent
 
Synthetic Reagent and Its Applications (M. Pharm)
Synthetic Reagent and Its Applications (M. Pharm)Synthetic Reagent and Its Applications (M. Pharm)
Synthetic Reagent and Its Applications (M. Pharm)
 
Protecting Groups In Organic Synthesis
Protecting Groups In Organic SynthesisProtecting Groups In Organic Synthesis
Protecting Groups In Organic Synthesis
 
Suzuki and Shapiro reaction
Suzuki and Shapiro reaction Suzuki and Shapiro reaction
Suzuki and Shapiro reaction
 
Nitration
NitrationNitration
Nitration
 
organic reaction
organic reactionorganic reaction
organic reaction
 
Pinner pyrimidine synthesis
Pinner pyrimidine  synthesisPinner pyrimidine  synthesis
Pinner pyrimidine synthesis
 
Advanced Organic Chemistry - I
Advanced Organic Chemistry - IAdvanced Organic Chemistry - I
Advanced Organic Chemistry - I
 
Enatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTS
Enatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTSEnatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTS
Enatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTS
 
MITSUNUBU REACTION.pptx
MITSUNUBU REACTION.pptxMITSUNUBU REACTION.pptx
MITSUNUBU REACTION.pptx
 
knorr pyrazole synthesis
knorr pyrazole synthesisknorr pyrazole synthesis
knorr pyrazole synthesis
 
Ullmann reaction
Ullmann reaction   Ullmann reaction
Ullmann reaction
 
Heterocyclic compounds
Heterocyclic compoundsHeterocyclic compounds
Heterocyclic compounds
 
Asymmetric synthesis | chemistry presentation | 2021
Asymmetric synthesis | chemistry presentation | 2021 Asymmetric synthesis | chemistry presentation | 2021
Asymmetric synthesis | chemistry presentation | 2021
 
Strategies for Heterocycle ring synthesis
Strategies for Heterocycle ring synthesis Strategies for Heterocycle ring synthesis
Strategies for Heterocycle ring synthesis
 
Wittig reagent
Wittig reagentWittig reagent
Wittig reagent
 
Asymmetric Synthesis Mpharm 1St year
Asymmetric Synthesis Mpharm 1St yearAsymmetric Synthesis Mpharm 1St year
Asymmetric Synthesis Mpharm 1St year
 
Side reaction in peptide synthesis
Side reaction in peptide synthesisSide reaction in peptide synthesis
Side reaction in peptide synthesis
 

Similar to Asymmetric synthesis M.pharm 1st year

Asymmetric synthesis
Asymmetric synthesis Asymmetric synthesis
Asymmetric synthesis
AtulBendale2
 
Amino acids proteins and peptide.pptx
Amino acids proteins and peptide.pptxAmino acids proteins and peptide.pptx
Amino acids proteins and peptide.pptx
SATISH KOLA
 
Asymmetric Synthesis - Christeena Shaji
Asymmetric Synthesis - Christeena ShajiAsymmetric Synthesis - Christeena Shaji
Asymmetric Synthesis - Christeena Shaji
Bebeto G
 
PROTEINS.pdf
PROTEINS.pdfPROTEINS.pdf
PROTEINS.pdf
Lyka93286
 
1_merged (1).pptx
1_merged (1).pptx1_merged (1).pptx
1_merged (1).pptx
EYOBDEBEBEAREGA
 
123713AB lecture06
123713AB lecture06123713AB lecture06
123713AB lecture06
Gareth Rowlands
 
Group 10
Group  10 Group  10
Group 10
daisy salindato
 
Advantages Of Biodegradable Polymers
Advantages Of Biodegradable PolymersAdvantages Of Biodegradable Polymers
Advantages Of Biodegradable Polymers
Rikki Wright
 
Asymmetric synthesis
Asymmetric synthesisAsymmetric synthesis
Asymmetric synthesis
faixan_live
 
Molecular rearrangements involving electron deficient nitrogen as an intermed...
Molecular rearrangements involving electron deficient nitrogen as an intermed...Molecular rearrangements involving electron deficient nitrogen as an intermed...
Molecular rearrangements involving electron deficient nitrogen as an intermed...
CCSU
 
HOMOGENEOUS CATALYTC REACTIONS.pptx
HOMOGENEOUS CATALYTC REACTIONS.pptxHOMOGENEOUS CATALYTC REACTIONS.pptx
HOMOGENEOUS CATALYTC REACTIONS.pptx
Sunmbal Awais
 
Micro-reviewer-3.docx
Micro-reviewer-3.docxMicro-reviewer-3.docx
Micro-reviewer-3.docx
AvelinoPampanganDega
 
Enzymes
EnzymesEnzymes
Condensation reactions
Condensation reactions Condensation reactions
Condensation reactions
Institute of Chemical Technology
 
Lecture 1 - General Properties of Amino Acids(2) (1).pdf
Lecture 1 - General Properties of Amino Acids(2) (1).pdfLecture 1 - General Properties of Amino Acids(2) (1).pdf
Lecture 1 - General Properties of Amino Acids(2) (1).pdf
KundaBwalya1
 
Isoquinoline.pptx
Isoquinoline.pptxIsoquinoline.pptx
Isoquinoline.pptx
Mohammad Rana Hossain
 
Retrosynthesis
RetrosynthesisRetrosynthesis
Retrosynthesis
madhuprasanth2
 
Retrosynthesis Introduction
Retrosynthesis IntroductionRetrosynthesis Introduction
Retrosynthesis Introduction
madhuprasanth2
 
Carboxylic Acids.pptx
Carboxylic Acids.pptxCarboxylic Acids.pptx
Carboxylic Acids.pptx
MarMary6
 

Similar to Asymmetric synthesis M.pharm 1st year (20)

Asymmetric synthesis
Asymmetric synthesis Asymmetric synthesis
Asymmetric synthesis
 
Amino acids proteins and peptide.pptx
Amino acids proteins and peptide.pptxAmino acids proteins and peptide.pptx
Amino acids proteins and peptide.pptx
 
Asymmetric Synthesis - Christeena Shaji
Asymmetric Synthesis - Christeena ShajiAsymmetric Synthesis - Christeena Shaji
Asymmetric Synthesis - Christeena Shaji
 
PROTEINS.pdf
PROTEINS.pdfPROTEINS.pdf
PROTEINS.pdf
 
1_merged (1).pptx
1_merged (1).pptx1_merged (1).pptx
1_merged (1).pptx
 
123713AB lecture06
123713AB lecture06123713AB lecture06
123713AB lecture06
 
Group 10
Group  10 Group  10
Group 10
 
Advantages Of Biodegradable Polymers
Advantages Of Biodegradable PolymersAdvantages Of Biodegradable Polymers
Advantages Of Biodegradable Polymers
 
Asymmetric synthesis
Asymmetric synthesisAsymmetric synthesis
Asymmetric synthesis
 
Molecular rearrangements involving electron deficient nitrogen as an intermed...
Molecular rearrangements involving electron deficient nitrogen as an intermed...Molecular rearrangements involving electron deficient nitrogen as an intermed...
Molecular rearrangements involving electron deficient nitrogen as an intermed...
 
HOMOGENEOUS CATALYTC REACTIONS.pptx
HOMOGENEOUS CATALYTC REACTIONS.pptxHOMOGENEOUS CATALYTC REACTIONS.pptx
HOMOGENEOUS CATALYTC REACTIONS.pptx
 
Carbonyl4
Carbonyl4Carbonyl4
Carbonyl4
 
Micro-reviewer-3.docx
Micro-reviewer-3.docxMicro-reviewer-3.docx
Micro-reviewer-3.docx
 
Enzymes
EnzymesEnzymes
Enzymes
 
Condensation reactions
Condensation reactions Condensation reactions
Condensation reactions
 
Lecture 1 - General Properties of Amino Acids(2) (1).pdf
Lecture 1 - General Properties of Amino Acids(2) (1).pdfLecture 1 - General Properties of Amino Acids(2) (1).pdf
Lecture 1 - General Properties of Amino Acids(2) (1).pdf
 
Isoquinoline.pptx
Isoquinoline.pptxIsoquinoline.pptx
Isoquinoline.pptx
 
Retrosynthesis
RetrosynthesisRetrosynthesis
Retrosynthesis
 
Retrosynthesis Introduction
Retrosynthesis IntroductionRetrosynthesis Introduction
Retrosynthesis Introduction
 
Carboxylic Acids.pptx
Carboxylic Acids.pptxCarboxylic Acids.pptx
Carboxylic Acids.pptx
 

Recently uploaded

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 

Recently uploaded (20)

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 

Asymmetric synthesis M.pharm 1st year

  • 1. By KARISHMA SURESH ASNANI Guided by Ms. Pradnya Gondane Mam GURUNANAK COLLEGE OF PHARMACY
  • 2. ASYMMETRIC SYNTHESIS  Enantioselective synthesis, also called asymmetric synthesis, is a form of chemical synthesis. It is defined by IUPAC as: a chemical reaction (or reaction sequence) in which one or more new elements of chirality are formed in a substrate molecule and which produces the stereoisomeric (enantiomeric or diastereoisomeric) products in unequal amounts.  Put more simply: it is the synthesis of a compound by a method that favors the formation of a specific enantiomer or diastereomer. Enantiomers are stereoisomers that have opposite configurations at every chiral center. Diastereomers are stereoisomers that differ at one or more chiral centers.  Enantioselective synthesis is a key process in modern chemistry and is particularly important in the field of pharmaceuticals, as the different enantiomers or diastereomers of a molecule often have different biological activity.
  • 3. THE CHIRAL POOL: NATURE’S CHIRAL CENTRES ‘OFF THE SHELF’ A laboratory synthesis of a chiral compound from achiral or racemic starting material alone always gives a racemic mixtures of enantiomers.  If you want to make just one enantiomer, you have to use a starting material or reagents which is also just one enantiomer.  These enantiomerically pure compounds are present in abundance in nature which are collectively known as the ‘chiral pool’.  The principle groups of compounds in the chiral pool are: 1. Amino acids and their derivatives 2. Carbohydrates and their derivatives
  • 4. AMINO ACIDS AND THEIR DERIVATIVES  There are n number of amino acids found in proteins, out of which some of them are given below.  These amino acids have simple side chain that are simple alkyl groups or functionalized chains with plenty of versatile chemistry, and can be obtained by hydrolysis of protein.
  • 5. Simple derivatives of the amino acids AMINO ALCOHOL: It’s easy to reduce amino acids to amino alcohols with borane (BH3), usually generated in the reaction mixture by treating sodium borohydride with concentrated sulfuric acid.  Ephedrine is an amino alcohol which is itself a useful member of the chiral pool—it’s a plant extract readily available as either diastereoisomer, also available as either enantiomer.
  • 6.  HYDROXY ACID: It’s also easy to make hydroxy acids from amino acids by diazotization. Nitrous acid generates a diazonium salt, which undergoes substitution by water via an intermediate α-lactone. Two configurational inversions are involved, so the product alcohol retains S stereochemistry.  Some hydroxy acids are themselves available from nature, and are therefore also members of the chiral pool: both (R)- and (S)-lactic acid, for example, can be made by bacterial fermentation; mandelic, malic, and tartaric acids are extracted from almonds, apples, and grapes, respectively.
  • 7. CARBOHYDRATES AND THEIR DERIVATIVES.  There are a great many simple carbohydrates available, but one of the most useful is mannose. Reduction to the alcohol gives the C2- symmetric compound mannitol, which can be converted to a useful aldehyde by selective protection as a bis-acetal with acetone and a Lewis acid. Cleavage of the remaining diol with sodium periodate gives two equivalents of a useful protected form of glyceraldehyde.
  • 8.  There are varied ways in which members of the chiral pool can be put to work in asymmetric synthesis, but the most straightforward application is simply to spot that a target molecule has a close structural similarity with, say, an amino acid.  This is what Mori did when he made another important insect pheromone, ipsenol. The left-hand half of the molecule has the same structure as the side chain of leucine, and the S chiral centre can also come from (S)-leucine.  Mori used (S)-leucine as the starting material and converted it to the (S)-hydroxy acid. The hydroxyl group was protected as the THP derivative.
  • 9.  Reduction of the acid, via the ester, then allowed introduction of the tosylate leaving group, which was displaced to make an epoxide. The epoxide was opened by a Grignard reagent to introduce the diene portion and give the target molecule.
  • 10. CHIRAL AUXILIARIES  A chiral auxiliary is a stereogenic group or unit that is temporarily incorporated into an organic compound in order to control the stereochemical outcome of the synthesis. The chirality present in the auxiliary can bias the stereoselectivity of one or more subsequent reactions. The auxiliary can then be typically recovered for future use.
  • 11.  Diastereoselective reactions work just as well whether the starting material is racemic or enantiomerically pure—you get the same diastereoisomeric outcome in each case, but if you start with racemic material you get racemic product and if you start with enantiomerically pure material you get enantiomerically pure product.  So if you use a starting material from the chiral pool, you can build new chiral centres in enantiomerically pure form just by using diastereoselective reactions. The chiral pool starting materials (S)-lactic acid and (S)-serine were converted to two natural products using a series of diastereoselective reactions to introduce further chiral centres into the molecules.
  • 12.  The syntheses rely on the fact that the structure of the chiral pool starting material is still there in the product. But the same idea can work even if the starting chiral compound is no longer part of the target you are making. In this case the chiral starting material is called a chiral auxiliary. Chiral auxiliaries are extremely versatile because they can be used to make a whole variety of target molecules in enantiomerically pure form.
  • 13. OXAZOLIDINONES AUXILLARIES  Oxazolidinone auxiliaries, popularized by David Evans, have been applied to many stereoselective transformations, including aldol reactions, alkylation reactions, and Diels-Alder reactions. The oxazolidinones are substituted at the 4 and 5 positions. Through steric hindrance, the substituents direct the direction of substitution of various groups. The auxiliary is subsequently removed e.g. through hydrolysis.  PREPARATION: Oxazolidinones can be prepared from amino acids or readily available amino alcohols. A large number of oxazolidinones are commercially available, including the four below.
  • 14.  ALKYLATION REACTIONS  Deprotonation at the α-carbon of an oxazolidinone imide with a strong base such as lithium diisopropylamide selectively furnishes the (Z)- enolate, which can undergo stereoselective alkylation.  Alkylation of an oxazolidinone imide with benzyl bromide.  Activated electrophiles, such as allylic or benzylic halides, are very good substrates.
  • 15. Removal A variety of transformations have been developed to facilitate removal of the oxazolidinone auxiliary to generate different synthetically useful functional groups.
  • 16. ASYMMETRIC CATALYSIS  Definition: Asymmetric catalysis is a type of catalysis in which a chiral catalyst directs the formation of a chiral compound such that formation of one particular stereoisomer is favoured. 1. Catalytic asymmetric reduction of ketones 2. Catalytic asymmetric hydrogenation of alkenes 3. Asymmetric epoxidation 4. Asymmetric dihydroxylation 5. Ligand-accelerated catalysis
  • 17. CATALYTIC ASYMMETRIC REDUCTION OF KETONES  One of the simplest transformations you could imagine of a prochiral unit into a chiral one is the reduction of a ketone. Although chiral auxiliary strategies have been used to make this type of reaction asymmetric, conceptually the simplest way of getting the product as a single enantiomer would be to use a chiral reducing agent—in other words, to attach the chiral influence not to the substrate (as we did with chiral auxiliaries) but to the reagent. We need an asymmetric version of NaBH4.
  • 18.  One of the more widely used solutions to this challenge is the chiral borohydride analogue invented by Itsuno in Japan and developed by Corey, Bakshi, and Shibata. It is based on a stable boron heterocycle made from an amino alcohol derived from proline, and is known as the CBS catalyst after its developers.  The active reducing agent is generated when the heterocycle forms a complex with borane. Only catalytic amounts (usually about 10%) of the boron heterocycle are needed because borane is suffi ciently reactive to reduce ketones only when complexed with the nitrogen atom. The rest of the borane just waits until a molecule of catalyst becomes free.
  • 19.  INTERACTIVE ASYMMETRIC REDUCTION OF KETONE WITH CBS CATALYST
  • 20.  Until recently, the CBS reagent was one of the most commonly used asymmetric reducing agents for ketones. But in the early years of the 21st century a new reaction has taken over that role—one in which the job of bringing together the ketone and the reducing agent is taken by an atom of ruthenium.  The ruthenium is added as Ru(II) in a 16-electron complex with an aromatic compound such as 1,3,5-trimethylbenzene (known as mesitylene).  A chiral ligand is needed—the diamine derivative shown here is best. Only very small amounts (often << 1%) of the catalyst and ligand are required, which is a good thing as both are much more expensive than the reagents in the CBS reduction.  The reducing agent itself can be hydrogen or, more conveniently, a more easily handled source of hydrogen atoms such as isopropanol (which gets oxidized to acetone) or formic acid (which gets oxidized to carbon dioxide).  Here’s a typical example; will explain how it works shortly.
  • 21. The ruthenium-catalysed reduction of ketones starts with coordination of the tosyl-diamine ligand ((S,S)-N-toluenesulfonyl 1,2-phenylenediamine, or ‘TsDPEN’) to the ruthenium metal. This is a 16-electron complex, and can be reduced by formic acid to an 18-electron ruthenium hydride.
  • 22.
  • 23. EXAMPLE The reduction shown below is particularly important because it generates a late intermediate in the industrial synthesis of the anti-asthma drug montelukast (Singulair). Several methods have been used, but in 2008 chemists at the Croatian pharmaceutical company Pliva patented a method using the ruthenium catalyst with a derivative of TsDPEN as a ligand to gives the product in 83% yield and 99.8% ee on a scale of several kilograms.
  • 24. CATALYTIC ASYMMETRIC HYDROGENATION OF ALKENES  Reduction of a ketone can give a chiral secondary alcohol, but reduction of an alkene by addition of hydrogen to one of its two enantiotopic faces can give all sorts of products, creating either one or two chiral centres, depending on the substituents on the alkene.  You have seen numerous hydrogenations of alkenes using hydrogen over a solid catalyst of palladium supported on charcoal (‘heterogeneous hydrogenation’), but catalytic asymmetric hydrogenation of alkenes uses a different type of catalyst—a soluble complex, often of Ru or Rh with phosphine-containing ligands.  The substrates for asymmetric alkene hydrogenation are also more limited than those for hydrogenation with Pd/C because they must carry a functional group close to the alkene, allowing coordination to the transition metal catalyst.
  • 25.
  • 26. Two important industrial asymmetric syntheses which routinely use this chemistry are the production of the painkiller (S)-naproxen and the synthetic intermediate and perfumery compound (R)-citronellol. It is gratifying to note that this chemistry, using
  • 27. Asymmetric epoxidation  Asymmetric hydrogenation of an alkene can create two new chiral centres, but introduces no new functionality as it does so. Asymmetric oxidation of an alkene is different: it can create two new chiral centres and two new functional groups at the same time.  This reaction makes use of titanium, as titanium tetraisopropoxide, Ti(Oi-Pr)4.  Sharpless and his co-worker Tsutomu Katsuki surmised that by adding a chiral ligand to the titanium catalyst they might be able to make the reaction asymmetric. The ligand that works best is diethyl tartrate, and one example of the reaction is shown below.
  • 28.  Jacobsen asymmetric epoxidation of indene  This epoxide plays a starring role in the synthesis of the antiHIV compound indinavir.
  • 29. ASYMMETRIC DIHYDROXYLATION  The active reagent is based on osmium(VIII) and is used in just catalytic amounts.  This means that there has to be a stoichiometric quantity of another oxidant to reoxidize the osmium after each catalytic cycle—K3Fe(CN)6 is most commonly used.  Because OsO4 is volatile and toxic, the osmium is usually added as K2OsO2(OH)4, which forms OsO4 in the reaction mixture.  The ‘other additives’ include K2CO3 and methanesulfonamide (MeSO2NH2), which increases the rate of the reaction by regenerating the catalyst at the end of each catalytic cycle.
  • 30.  Now for the chiral ligand.  Tertiary amines are good ligands for osmium and increase the rate of dihydroxylations: one of the reasons that NMO is used in the racemic version of the reaction is that the by-product, N-methylmorpholine, accelerates the reaction.  Sharpless chose some available chiral tertiary amines as ligands, and it turned out that the best ones are based on the alkaloids dihydroquinidine and dihydroquinine, whose structures are shown below.  They coordinate to the osmium through the green nitrogen atom.
  • 31.  The alkaloids (usually abbreviated to DHQD and DHQ, respectively) must be attached to an aromatic group Ar, the choice of which varies according to the substrate.  The most generally applicable ligands are these two phthalazines in which each aromatic group Ar carries two alkaloid ligands, either DHQ or DHQD.  Dihydroquinine and dihydroquinidine are not enantiomeric, but they act on the dihydroxylation as though they were.
  • 32. EXAMPLE trans-Stilbene dihydroxylates more selectively than any other alkene, and this particular example is one of the most enantioselective catalytic reactions ever invented.
  • 33. LIGAND-ACCELERATED CATALYSIS  Asymmetric dihydroxylation is such a good reaction not just because of the careful way in which the ligands have been designed.  It is a good reaction for a more fundamental reason: the reaction on which it is based (osmium-catalysed dihydroxylation) works only very poorly in the absence of the amine ligand.  The chiral amine ligands don’t just provide a chiral environment, they accelerate the reaction at the same time.  In any asymmetric reaction, we want the reagents to combine with one another only in the presence of the asymmetric infl uence provided by the chiral ligands.  If the reaction works anyway, even without the chiral ligands, we have an uphill struggle because the reagents are quite capable of producing racemic product on their own.
  • 34.
  • 35. STEREOSELECTIVITY  In chemistry, stereoselectivity is the property of a chemical reaction in which a single reactant forms an unequal mixture of stereoisomers during a non-stereospecific creation of a new stereocenter or during a non-stereospecific transformation of a pre-existing one. The selectivity arises from differences in steric effects and electronic effects in the mechanistic pathways leading to the different products. Stereoselectivity can vary in degree but it can never be total since the activation energy difference between the two pathways is finite. Both products are at least possible and merely differ in amount. However, in favorable cases, the minor stereoisomer may not be detectable by the analytic methods used.
  • 36.  An enantioselective reaction is one in which one enantiomer is formed in preference to the other, in a reaction that creates an optically active product from an achiral starting material, using either a chiral catalyst, an enzyme or a chiral reagent. The degree of selectivity is measured by the enantiomeric excess. An important variant is kinetic resolution, in which a pre-existing chiral center undergoes reaction with a chiral catalyst, an enzyme or a chiral reagent such that one enantiomer reacts faster than the other and leaves behind the less reactive enantiomer, or in which a pre-existing chiral center influences the reactivity of a reaction center elsewhere in the same molecule.  A diastereoselective reaction is one in which one diastereomer is formed in preference to another (or in which a subset of all possible diastereomers dominates the product mixture), establishing a preferred relative stereochemistry. In this case, either two or more chiral centers are formed at once such that one relative stereochemistry is favored, or a pre-existing chiral center (which needs not be optically pure) biases the stereochemical outcome during the creation of another. The degree of relative selectivity is measured by the diastereomeric excess.